Tobramycin Sulfate Injection 40 mg/mL Multiple Dose 2 mL x 25/Tray (RX)

Tobramycin Sulfate Injection 40 mg/mL is a high-potency antibiotic for serious bacterial infections. This sterile injectable solution (80 mg per 2 mL vial) contains tobramycin sulfate – an aminoglycoside broad-spectrum antibiotic – in a convenient 2 mL multi-dose vial. Each tray includes 25 vials, ensuring a reliable supply for hospital pharmacies and clinical settings. Fresenius Kabi’s pharmaceutical-grade manufacturing guarantees consistent, highly purified medication that meets strict quality standards. Tobramycin Injection comes ready-to-use for intravenous infusion (after appropriate dilution) and is intended for use under doctor supervision in acute care.

Tobramycin Sulfate Injection 40 mg/mL by Fresenius Kabi is a potent, broad-spectrum aminoglycoside antibiotic trusted by healthcare professionals for the treatment of serious bacterial infections. Supplied in convenient 2 mL multiple-dose vials (25 per tray), this injectable solution delivers consistent, pharmacy-grade efficacy in hospital and clinical settings.

Uses

• Treatment of serious bacterial infections caused by susceptible Gram-negative and certain Gram-positive organisms, including:
  • Septicemia
  • Lower respiratory tract infections
  • Urinary tract infections
  • Intra-abdominal infections
  • Skin, bone, and soft tissue infections
  • Central nervous system infections (meningitis)
  • Infections in immunocompromised patients
• Ideal for complicated or hospital-acquired infections where alternative antibiotics may not be effective

Benefits

• Broad-Spectrum Efficacy: Effective against a wide range of serious and multidrug-resistant infections
• Consistent, Potent Dosage: Precise 40 mg/mL formulation for dose accuracy and reliable clinical results
• Multiple-Dose Vials: Cost-efficient, reduces waste, and supports flexible dosing schedules
• Quick Onset: Rapid bactericidal action supports swift infection control
• Pharmacy-Grade Quality: Manufactured by Fresenius Kabi, a leader in hospital injectables

Directions for Use

For healthcare professionals only. Always follow approved institutional protocols and prescriber instructions.

1. Verify the vial label and solution clarity before each use. Do not use if the solution is cloudy or contains particulate matter.
2. Select administration route as prescribed—IM or IV.
3. Dosage: Individualized based on infection severity, patient weight, and renal function; consult full prescribing information for recommended dosing.
4. Withdraw prescribed dose using aseptic technique from the vial.
5. Administer as a slow IV injection/infusion or deep IM injection, as ordered by the physician.
6. Monitor renal and auditory function, as well as serum drug levels, as tobramycin has a narrow therapeutic index.
7. Use within recommended time frame after first vial puncture, and discard any unused portion properly.

Specifications

• Brand: Fresenius Kabi
• Generic Name: Tobramycin Sulfate Injection, USP
• Strength: 40 mg/mL
• Volume: 2 mL per vial
• Packaging: 25 multiple-dose vials per tray
• NDC: 63323-0306-02
• Product Number: 030602
• Administration Route: Intramuscular (IM) or intravenous (IV) injection
• Sterility: Sterile, preservative-free
• Latex-Free: Yes
• Prescription Required: Yes
• Professional Use: For hospital, clinic, and pharmacy settings

Side Effects

• Common: Injection site pain, redness, or swelling
• Possible: Headache, fatigue, fever, rash, or gastrointestinal upset (nausea, vomiting)
• Serious (rare): Nephrotoxicity (kidney damage), ototoxicity (hearing loss, tinnitus, balance issues), neuromuscular blockade, allergic reactions (anaphylaxis, urticaria, itching)

Seek immediate medical help for signs of allergic reaction, persistent dizziness, ringing in ears, hearing changes, or reduced urine output.

Warnings & Precautions

• Use only under medical supervision.
• Monitor renal (kidney) and auditory function before and during therapy—higher risk in elderly, dehydrated, and pre-existing kidney impairment.
• Do not administer with other drugs known for nephrotoxic or ototoxic potential unless strictly necessary and with caution.
• Pregnancy Category D: Use during pregnancy only if potential benefit justifies the potential risk to the fetus.
• May cause fetal harm, hearing loss, or kidney damage if administered during pregnancy.
• Dosage adjustment required in patients with renal impairment.
• Avoid mixing with other medications in the same syringe or IV solution unless compatibility is established.
• Keep out of reach of children.
• Store at recommended temperature and protect from light.

Why Choose Tobramycin Sulfate Injection by Fresenius Kabi?

• Trusted by hospitals and healthcare professionals worldwide
• Powerful broad-spectrum antibiotic coverage for life-threatening infections
• Ready-to-use, multi-dose vials support efficient hospital pharmacy workflow

Order Tobramycin Sulfate Injection 40 mg/mL Multiple Dose 2 mL x 25/Tray by Fresenius Kabi (NDC: 63323-0306-02, Product Number: 030602) today for reliable, hospital-grade infection management when it matters most!